The effect of vaginal progesterone suppository on prevention of preterm delivery by Lalooha, Fatemeh et al.
Scientific Journal of Kurdistan University of Medical Sciences No.100/ Jun-Jul 2019/111-118 
The effect of vaginal progesterone suppository on prevention of preterm 
delivery 
Lalooha F1, Movahed F2, Chegini V3, Pakniat H3, Takaloo F4 
1. Associate Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, 
Qazvin University of Medical Sciences, Qazvin, Iran. 
2. Associate Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, 
Qazvin University of Medical Sciences, Qazvin, Iran (Corresponding Author), Tel: +98-2833236380, Email: 
drmovahed@yahoo.com 
3. Assistant Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, 
Qazvin University of Medical Sciences, Qazvin, Iran. 
4. Specialist of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, Qazvin 
University of Medical Sciences, Qazvin, Iran. 
ABSTRACT 
Background and Aim: Preterm labor (PTL) is considered as one of the main causes of fetal mortality 
worldwide. Therefore, prevention of PTL is one of the main goals of midwifery care. The present study 
was conducted to determine the effect of vaginal progesterone suppository on the prevention of PTL. 
Materials and Method: In this randomized clinical trial, 200 singleton pregnant women at 24-34 weeks of 
gestation with diagnosis of PTL were treated with IV magnesium sulfate and corticosteroid. In the 
intervention group (n=100),in addition to the above mentioned drugs, progesterone suppository (200 mg) 
was administered at the start of treatment and every12 hours until discontinuation of uterine 
contractions. After successful tocolysis, use of progesterone suppository continued until the end of the 
34thweek.Midwifery outcome including the interval between the onset of tocolysis and discontinuation 
of uterine contractions and the occurrence of labor, the gestational age at the time of delivery and 
neonatal outcome were recorded in the two groups. 
Results: The mean intervals between the start of tocolysis and discontinuation of uterine contractions 
were 6.33±3.78 and 6.72±3.07 hours (p=0.432) in the control and intervention groups respectively. Also, 
the intervals between successful tocolysis and delivery were35.1±21.9 and 36.7±25.1 days respectively 
(p=0.634).There was no significant difference between the two groups in terms of gestational age at the 
time of delivery and neonatal outcome. Although neonatal mortality in the control group was twice that 
in the intervention group, the difference was not significant (p=0.194). 
Conclusion: The present study showed that vaginal progesterone suppository had no effect on the 
prevention of PTL. 
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